Stem cell therapy with neural precursor cells (NPCs) has the potential to improve
neuroregeneration after spinal cord injury (SCI). Unfortunately, survival and differentiation of …

Background aims Several studies have reported functional improvement after
transplantation of in vivo-derived neural progenitor cells (NPC) into injured spinal cord …

A spinal cord injury (SCI) is a destructive event that causes a permanent deficit in
neurological function because of poor regenerative potential. Transplantation therapies …

Neural stem/progenitor cell (NSPC) transplantation is a promising therapy for spinal cord
injury (SCI). However, little is known about NSPC from the adult human spinal cord as a …

Stem cell treatments, and in particular, stem cell transplants have been identified as
potential therapeutic strategies for a range of neurodegenerative and acquired conditions of …

Introduction: There have been a wide range of preclinical studies testing cellular therapies to
repair the injured spinal cord, yet they remain a challenge to translate because of …

Adult neural progenitor cells (NPCs) are an attractive source for functional replacement in
neurodegenerative diseases and traumatic injury to the central nervous system (CNS). It has …

Endogenous repair after injury in the adult CNS is limited by a number of factors including
cellular loss, inflammation, cavitation and glial scarring. Spinal cord neural progenitor cells …

Long-term survival and integration of neural progenitor cells (NPCs) transplanted following
spinal cord injury (SCI) have been observed. However, questions concerning the …

Spinal cord injury (SCI) is a devastating event, and there are still no effective therapies
currently available. Neural stem cells (NSCs) have gained increasing attention as promising …